Oral composition containing a salivation inducing agent

Details for Australian Patent Application No. 2006297129 (hide)

Owner McNeil-PPC, Inc.

Inventors Wynn, David W.; Robinson, Ronni

Agent Shelston IP

Pub. Number AU-A-2006297129

PCT Pub. Number WO2007/041367

Priority 11/239,974 30.09.05 US

Filing date 28 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 36/28 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041367 Priority application(s): WO2007/041367

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006297130-DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection

2006297128-Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes